Close Menu

NEW YORK – Eurofins Genomics today announced it has acquired Blue Heron Biotech.

Blue Heron, based in Bothell, Washington, specializes in gene synthesis and DNA design.

"Since DNA oligonucleotides play an integral role in genes, the deal will bolster Blue Heron's production capabilities as well as expand Eurofins Genomics' gene portfolio into cloning and complex gene constructs," Eurofins Genomics said in a statement. The firm added that the acquisition strengthens its offerings in the synthetic biology market.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New research shows that scientists need to do a better job of including a wider diversity of African genomes in their analyses, STAT says.

A new paper in Science shows that men are still winning a large majority of the most sought-after NIH grants.

Nature Research and the Estée Lauder Companies are awarding efforts to encourage girls to pursue careers in the STEM fields.

In Science this week: beneficial genetic variants inherited from archaic Neanderthal and Denisovan hominins, and more.